The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / EULAR 2013: Emerging Imaging Methods in Spondylarthritis Have Advantages and Flaws

EULAR 2013: Emerging Imaging Methods in Spondylarthritis Have Advantages and Flaws

September 1, 2013 • By Thomas R. Collins

  • Tweet
  • Email
Print-Friendly Version / Save PDF

You Might Also Like
  • EULAR 2015: Imaging in Rheumatology
  • EULAR 2015: Emerging Concepts, Treatments for Axial Spondyloarthritis
  • EULAR 2013: Researchers Make Inroads in Treatment of Osteoarthritis
Explore This Issue
September 2013
Also By This Author
  • Emerging Biomarkers for Lupus
NSAIDs, TNF inhibiotrs, and biologics may all be important treatments for spondylarthropies.
Osteoarthritis of knee. Color of a side view of the knee joint of a 33-year-old male with OA. Due to OA, the end of the femur is eroded and jagged; cracks causing weakening in both bones are also visible.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

MADRID—New imaging technologies in spondylarthritis (SpA)—from diffusion-weighted imaging to ultrasonography—are being studied and refined, but much is yet be understood, said Anne Grethe Jurik, MD, clinical associate professor of diagnostic radiology at Aarhus University in Denmark, here at the European League Against Rheumatism (EULAR) 2013 Annual European Congress of Rheumatology, held June 12–15.

Imaging in SpA

The mainstay, magnetic resonance imaging (MRI), is a sensitive technique, but normal variants can sometimes lead radiologists and physicians astray, resulting in false positives, she cautioned.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Jurik’s review came as part of a session on imaging techniques on SpA, osteoarthritis, and gout.

MRI activity changes in the sacroiliac joints (SIJs) that are consistent with SpA can also occurin individuals without SpA. Single lesions on MRI suggestive of inflammation have been reported in the SIJs in up to a quarter of young patients with mechanical back pain and healthy controls, studies have found.1

Normal variants can occur fairly frequently. Accessory sacroiliac joint has been seen in as many as 19% of subjects, iliosacral complex in 10%, and bipartite iliac bony plate in nearly 6%, Dr. Jurik said.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

The Assessment of Spondyloarthritis International Society (ASAS) criteria for sacroiliitis is bone marrow edema seen using short inversion time recovery (STIR) or osteitis on T1 postcontrast images located in typical subchondral or periarticular bone areas—but the criteria don’t include structural changes, even though those can occur within the first two years of the disease.

“There is a need for revision of the ASAS MR criteria, with inclusion of structural changes,” Dr. Jurik said.

As for other techniques, whole-body MRI (WB-MRI) of the sacroiliac joints and spine can reliably detect inflammatory SIJs and spinal lesions in SpA patients, compared with conventional MRI, she said. There also might be value in imaging the anterior chest wall and enthesitis with this method, she said.

Studies have found that WB-MRI, including postcontrast sequence, detects significantly more areas of synovitis and enthesitis in SpA than through clinical means, except in the hands and feet, she said.2

Dr. Jurik said diffusion-weighted MRI, based on the movement of water protons, might be a way to diagnose early active sacroiliitis and includes the possibility of objectively quantifying inflammation using apparent diffusion coefficient values.

As for ultrasound, color Doppler can be useful in diagnosing active inflammation in the ligamentous part of the SIJs at or posterior enthuses, but can’t pick up intraosseous inflammation. Power Doppler, more sensitive than color Doppler, gives reliable detection of peripheral enthesitis in SpA patients, Dr. Jurik said.

Multislice computed tomography (CT), she said, can be useful in cases involving subtle radiographic SIJ changes or in detection of normal variants because it gives clear delineation of spinal structures. But, she cautioned that it has less sensitivity to soft tissue and bone marrow lesions than MRI, and involves a high dose of radiation.

She stressed that the review of these techniques is ongoing. “We have to analyze the value of new imaging techniques further,” she said.

Imaging for OA

In imaging for osteoarthritis (OA), there’s a strong correlation between symptoms and pathology from MRI, but radiology is probably good enough to guide treatment decisions in a normal clinical setting, said Frank Roemer, MD, associate professor of radiology at the University of Erlangen-Nuremberg in Germany and at the Boston University School of Medicine.

Both MRI and ultrasound can guide clinicians to targeted treatment based on tissue-specific pathology and anatomic location, and MRI can predict clinical outcomes, like total knee replacement, he said.

Ultrasound allows visualization of soft tissues in multiple planes, is inexpensive, and involves no radiation. Plus, no contrast agent is needed. At the same time, though, it is user dependent, the physical properties of sound limit how widely it can be applied, and documentation is difficult with this technique.

CT, however, gives high spatial resolution and isn’t user dependent. CT-arthrography might be useful in OA assessment, he said, though it involves radiation exposure and poor soft tissue contrast.

As for usefulness in clinical trials, both X-ray and MRI are valuable tools for diagnosis and assessment of progression, although X-ray is limited in its ability to detect joint space narrowing, Dr. Roemer said.

MRI gives direct visualization of the cartilage and other OA features, such as bone marrow abnormalities, synovitis, effusion, and ligaments, and is reproducible in multicenter studies. Plus, MRI can detect OA features before they can be found on radiography. “MRI does overcome some of the limitations of radiography,” he said.

Imaging in osteoarthritis is headed toward better early targeting of OA pathology, more than just cartilage damage, along with identifying patients at high risk, or those likely to be “fast progressors,” Dr. Roemer said.

“Maybe advanced imaging technology will help us to monitor and target treatment much better,” he said.

Imaging for Gout

In imaging for gout, Kay Hermann, MD, senior consultant in the department of radiology at Charite University Hospital in Berlin, cautioned that X-rays are not sensitive at the early stages.

In one study of 27 patients with gout, but with normal X-rays, MRI and ultrasound were performed on a symptomatic joint and an asymptomatic joint. Researchers found that a large percentage of patients with normal radiographs can have destructive arthropathy. Fifty-six percent of the patients were found to have erosions, with MRI much more sensitive than ultrasound.3

Dual-energy CT, with two X-ray beams used simultaneously, can be useful for specific detection of gouty tophi, while ultrasound is suited for finding faint gouty deposits on the surface of cartilage, Dr. Hermann said.

MRI, he said, can be used in more “unusual settings,” with the advantage that tophus volume measurements are possible.


Thomas Collins is a freelance medical writer based in Florida.

References

  1. Weber U, Lambert RG, Østergaard M, Hodler J, Pedersen SJ, Maksymowych WP. The diagnostic utility of magnetic resonance imaging in spondylarthritis: An international multicenter evaluation of one hundred eighty-seven subjects. Arthritis Rheum. 2010;62:3048-3058.
  2. Weckbach S, Schewe S, Michaely HJ, Steffinger D, Reiser MF, Glaser C. Whole-body MR imaging in psoriatic arthritis: Additional value for therapeutic decision making. European J Radiol. 77:149-155.
  3. Carter JD, Kedar RP, Anderson SR, et al. An analysis of MRI and ultrasound imaging in patients with gout who have normal plain radiographs. Rheumatology. 2009;48:1442-1446.

Pages: 1 2 3 | Multi-Page

Filed Under: Conditions, Meeting Reports, Spondyloarthritis Tagged With: diffusion-weighted imaging, EULAR 2013, ultrasonographyIssue: September 2013

You Might Also Like:
  • EULAR 2015: Imaging in Rheumatology
  • EULAR 2015: Emerging Concepts, Treatments for Axial Spondyloarthritis
  • EULAR 2013: Researchers Make Inroads in Treatment of Osteoarthritis
  • EULAR 2013: Drugs New and Old Could Treat Spondylarthropies

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.